Demcizumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Demcizumab ?
Monoclonal antibody
Source Humanized (from mouse)
Target DLL4
Clinical data
Legal status ?
Identifiers
CAS number 1243262-17-0
ATC code None
Chemical data
Formula C6444H10004N1700O2028S52 
Mol. mass 145.3 kDa

Demcizumab is a humanized monoclonal antibody designed for the treatment of cancer.[1]

This drug was developed by OncoMed Pharmaceuticals.

References[edit]

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Demcizumab, American Medical Association.